Skip to main content
Year archive

Karo Pharma AB — 2020 filings

All 26 regulatory filings released by Karo Pharma AB (KARO) in 2020, sourced directly from the official regulator.

26 Filings
2020 Period
2020 filings (26)
Filing Released Lang
Karo Pharma AB divests its Hospital Supply business, Swereco AB, to J2L Holding AB
M&A Activity
2020-11-16 English
Karo Pharma AB avyttrar Hospital Supply-verksamheten, Swereco AB, till J2L Holding AB
Regulatory Filings
2020-11-16 Swedish
Earnings Release 2020
Earnings Release Q3 2020
2020-10-30 Swedish
Earnings Release 2020
Earnings Release Q3 2020
2020-10-30 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Q2 2020
2020-07-21 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q2 2020
2020-07-21 English
ÅRSSTÄMMA 2020 i KARO PHARMA AKTIEBOLAG
AGM Information
2020-05-25 Swedish
ANNUAL GENERAL MEETING 2020 IN KARO PHARMA AKTIEBOLAG
AGM Information
2020-05-25 English
Karo Pharma acquires Pevaryl[®] brand portfolio from Cilag GmbH International, an affiliate of Johnson & Johnson
M&A Activity
2020-05-08 English
Karo Pharma förvärvar Pevaryl [® ]produktportfölj av Cilag GmbH International, ett dotterbolag inom Johnson & Johnson
M&A Activity
2020-05-08 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-04-29 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-04-29 English
KALLELSE TILL ÅRSSTÄMMA I KARO PHARMA AKTIEBOLAG
AGM Information
2020-04-23 Swedish
Karo Pharma AB förvärvar Hygis SA och får därigenom direkt tillgång till den schweiziska marknaden
M&A Activity
2020-04-01 Swedish
Karo Pharma enters the Swiss market with direct presence by acquiring Hygis SA
M&A Activity
2020-04-01 English
Report Publication Announcement 2020
Report Publication Announcement
2020-04-01 Swedish
Report Publication Announcement 2020
Report Publication Announcement
2020-04-01 English
Karo Pharma senarelägger årsstämman till 25 maj, 2020
AGM Information
2020-03-27 Swedish
Karo Pharma postpones the Annual General Meeting to 25 May, 2020
AGM Information
2020-03-27 English
Karo Pharma completes the acquisition of product portfolio from LEO Pharma
M&A Activity
2020-03-02 English
Karo Pharma slutför förvärvet av produktportfölj från Leo Pharma
M&A Activity
2020-03-02 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report FY 2019
2020-02-19 Swedish
Audit Report / Information 2019
Audit Report / Information FY 2019
2020-02-19 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-13 English
Termination of Karo agreement with Pfizer
Regulatory Filings
2020-02-04 English
Karo Pharmas samarbetsavtal med Pfizer avslutas
Regulatory Filings
2020-02-04 Swedish